- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Disruptive, Impulse Control, and Conduct Disorders in New Zealand
Total 3008 results
-
Supernus Pharmaceuticals, Inc.CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
The University of New South WalesAustralian Government Department of Health and AgeingCompletedMulticomponent Risk Factor Intervention for People With a Severe Mental Illness: a Feasibility StudyBehavior, Addictive | Obesity | Psychotic DisorderAustralia
-
H. Lundbeck A/SCompletedAttention Deficit Hyperactivity DisorderUnited States
-
National Institute of Mental Health (NIMH)CompletedAutistic Disorder | Attention Deficit Disorder With Hyperactivity | Pervasive Development DisordersUnited States
-
SunovionCompleted
-
ShireCompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Alcobra Ltd.TerminatedAttention Deficit Hyperactivity Disorder (ADHD)United States, Israel
-
SunovionCompleted
-
MC2 TherapeuticsCompletedPhototoxicityUnited States
-
SunovionCompletedPediatric Attention Deficit Hyperactivity DisorderUnited States
-
Corium, Inc.Worldwide Clinical Trials; Premier Research Group plc; Almac; Prometrika, LLCRecruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Corium, Inc.Premier Research Group plc; Almac; Prometrika, LLCActive, not recruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Eli Lilly and CompanyCompletedAttention-Deficit/Hyperactivity DisorderCanada
-
AbbVie (prior sponsor, Abbott)CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Completed
-
ShireCompletedAttention-Deficit/Hyperactivity DisorderUnited States, Canada
-
Antipodean Pharmaceuticals, Inc.CompletedParkinson's DiseaseNew Zealand, Australia
-
ReCode TherapeuticsRecruitingPrimary Ciliary DyskinesiaUnited Kingdom, United States, Australia, New Zealand
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity Disorder | Oppositional Defiant DisorderAustralia, Belgium, Denmark, Finland, Germany, Netherlands, Spain, United Kingdom
-
CephalonCompletedADHD | Attention Deficit/Hyperactivity DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAdult Attention Deficit Hyperactivity DisorderUnited States
-
New River PharmaceuticalsCompletedAttention Deficit Hyperactivity Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersUnited States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
SunovionCompletedAdult Attention Deficit Hyperactivity DisorderUnited States
-
AbbVie (prior sponsor, Abbott)CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
ShireCompletedADHD Specifically With Executive Function ImpairmentUnited States
-
AbbottTerminatedAttention-Deficit/Hyperactivity DisorderUnited States
-
ShireCompletedAttention-Deficit/Hyperactivity DisorderUnited States, Poland, Spain, Canada, Hungary, Belgium, Germany, Italy, Sweden, United Kingdom
-
ShireCompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
SunovionCompleted
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States, Puerto Rico
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity Disorder | DyslexiaUnited States
-
American Foundation for Addiction ResearchUniversity of Alberta; University of Southern MississippiUnknownSexual AddictionUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA); Albert Einstein College of Medicine; University of Miami and other collaboratorsRecruitingOpioid AddictionUnited States, Puerto Rico
-
Kirsten MollerCompletedDelirium | Acute Brain Injury | Acquired Brain InjuriesDenmark
-
CephalonCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Dartmouth-Hitchcock Medical CenterNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Stress Disorders, Post-TraumaticUnited States
-
Theravance BiopharmaCompletedADHD | Attention-Deficit/Hyperactivity DisorderUnited States
-
AbbottCompletedADHD | Attention-Deficit/Hyperactivity DisorderUnited States
-
Cingulate TherapeuticsPremier Research Group plcActive, not recruitingADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Alcobra Ltd.CompletedADHD | Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive TypeUnited States, Israel
-
New River PharmaceuticalsShireCompletedAttention Deficit Hyperactivity Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersUnited States
-
Lane Strathearn, MBBS PhDYale UniversityTerminatedMaternal Behavior | Maternal AddictionUnited States